Status:
SUSPENDED
A Cardiac Registry to Evaluate and Manage the hsTnI Categorical CVD Risk in Subjects Undergoing Preventive Health Checks (PHC).
Lead Sponsor:
Jaime Marino
Collaborating Sponsors:
Apollo Hospitals Enterprise Limited
Conditions:
Cardiovascular Diseases
Eligibility:
All Genders
18+ years
Brief Summary
Cardiovascular disease is the leading cause of mortality globally. In India cardiovascular disease leads to death a decade earlier than in western countries. In the past 20 years awareness and classic...
Detailed Description
Development of high-sensitivity assays for cardiac troponin I (hs-TnI) has enhanced the ability to detect low circulating levels of cardiac troponins, which are often present in individuals with commo...
Eligibility Criteria
Inclusion
- All men and women above the age of 18 years
- Lipid profiles ordered
- HbA1c ordered
- Creatinine ordered
Exclusion
- 1\. Non-consenting subjects
Key Trial Info
Start Date :
September 12 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 12 2030
Estimated Enrollment :
300000 Patients enrolled
Trial Details
Trial ID
NCT04903041
Start Date
September 12 2019
End Date
September 12 2030
Last Update
November 28 2025
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
Apollo Hospitals
Bangalore, India
2
Apollo Hospitals
Chennai, India
3
Apollo Hospitals
Hyderabad, India
4
Apollo Hospitals
Kolkata, India